Alexander Chung

Author PubWeight™ 10.61^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers.	Nat Genet	2013	2.15
2	Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma.	Clin Cancer Res	2008	1.57
3	Sorafenib and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma.	J Cell Mol Med	2009	1.30
4	AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC).	J Hepatol	2009	1.12
5	Sorafenib induces growth suppression in mouse models of gastrointestinal stromal tumor.	Mol Cancer Ther	2009	1.07
6	Role of fenestration and resection for symptomatic solitary liver cysts.	ANZ J Surg	2005	1.01
7	AZD6244 (ARRY-142886) enhances the therapeutic efficacy of sorafenib in mouse models of gastric cancer.	Mol Cancer Ther	2009	0.93
8	p38delta/MAPK13 as a diagnostic marker for cholangiocarcinoma and its involvement in cell motility and invasion.	Int J Cancer	2010	0.89
9	Doctor-patient communication, knowledge, and question prompt lists in reducing preoperative anxiety: a randomized control study.	Asian J Surg	2012	0.86
10	Inflammatory pseudotumour of the liver mimicking cholangiocarcinoma.	Ann Acad Med Singapore	2013	0.75
11	Superior diaphragmatic adenopathy from primary hepatocellular carcinoma.	J Gastroenterol Hepatol	2003	0.75